IBER.WS
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
IBER.WS
Delisted
IBER.WS was delisted on the 15th of February, 2023.
33 hedge funds and large institutions have $2.43M invested in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
33
Holding in Top 10
–
Calls
$2.22M
Puts
–
Top Buyers
| 1 | +$32K | |
| 2 | +$12K | |
| 3 | +$7.51K | |
| 4 |
LCM
Lynwood Capital Management
Toronto,
Ontario, Canada
|
+$3K |
| 5 |
Walleye Capital
New York
|
+$73 |
Top Sellers
| 1 | -$53K | |
| 2 | -$5.86K | |
| 3 | -$4.96K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.07K |
| 5 |
PCM
Prelude Capital Management
New York
|
-$1.11K |